Holtzheimer Paul E, Mayberg Helen S
Departments of Psychiatry and Surgery, Dartmouth-Hitchcock Medical Center 5D, One Medical Center Drive, Lebanon NH 03756, USA.
F1000 Med Rep. 2012;4:22. doi: 10.3410/M4-22. Epub 2012 Nov 1.
Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical stimulation, and deep brain stimulation among others. Of these, only two (transcranial magnetic stimulation and vagus nerve stimulation) currently have US Food and Drug Administration approval for the treatment of depression.
难治性抑郁症影响着至少1%至3%的美国人口。本文回顾了用于难治性抑郁症的局灶性神经调节疗法的现状,重点关注那些已发表临床数据的治疗方法。这些方法包括经颅磁刺激、经颅直流电刺激、磁休克治疗、迷走神经刺激、直接皮层刺激以及深部脑刺激等。其中,目前只有两种(经颅磁刺激和迷走神经刺激)获得了美国食品药品监督管理局批准用于治疗抑郁症。